| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |